Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Silastic Stenting on Post-Operative Intra-Nasal Re-Mucosalization

NCT03282058 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT03282058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03282058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Silastic Stenting on Post-Operative Intra-Nasal Re-Mucosalization
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Unknown status
Start date
April 4, 2016
Completion date
December 31, 2018
Enrollment
26 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pituitary tumour